Pharmaceutical

Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan

At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.

Jan 16, 2025 - 06:00
Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan
At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.
Read the original article

Tags:

Previous Article

JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole

Next Article

Regenxbio and Nippon Shinyaku forge $810m gene therapy deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Hanmi and MEDiC ink cancer biomarker collaboration deal

Hanmi and MEDiC ink cancer biomarker collaboration deal

Oct 16, 2024

STAT+: Radiology captures the tension between AI’s potential and concern for patients

STAT+: Radiology captures the tension between AI’s pote...

Dec 1, 2023

STAT+: With weight loss drug ads, telehealth companies wade into a regulatory gray area

STAT+: With weight loss drug ads, telehealth companies ...

Apr 7, 2023